| 000 | 01691 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515062328.0 | ||
| 264 | 0 | _c20070807 | |
| 008 | 200708s 0 0 eng d | ||
| 022 | _a1462-0324 | ||
| 024 | 7 |
_a10.1093/rheumatology/kel453 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJois, R N | |
| 245 | 0 | 0 |
_aRituximab therapy in patients with resistant rheumatoid arthritis: real-life experience. _h[electronic resource] |
| 260 |
_bRheumatology (Oxford, England) _cJun 2007 |
||
| 300 |
_a980-2 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Resistance, Multiple |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylprednisolone _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aMasding, A | |
| 700 | 1 | _aSomerville, M | |
| 700 | 1 | _aGaffney, K | |
| 700 | 1 | _aScott, D G I | |
| 773 | 0 |
_tRheumatology (Oxford, England) _gvol. 46 _gno. 6 _gp. 980-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/rheumatology/kel453 _zAvailable from publisher's website |
| 999 |
_c16938540 _d16938540 |
||